Global Network
Deeply anchored across Eurasia (EAEU), Europe, Japan & Korea, and the Middle East to connect global life science ecosystems.
Corridor-Based Cross-Border Collaboration
Active collaboration network spanning 11 countries and regions across Europe, Eurasia, Asia-Pacific, and the Middle East.
Switzerland & Europe Innovation Hub
Connecting leading European clinical clusters with strict cGMP standards
Anchored across the Zurich–Lausanne biotech corridor and leading Italian pediatric hemato-oncology centers, we connect European R&D institutions, regulatory expectations, and industrial validation channels to accelerate bilateral process engineering and asset translation.
Japan & Korea Biomanufacturing Hub
Aligned with stringent PMDA quality systems and CDMO standards
Experienced in Japanese PMDA expectations, top-tier CDMO quality audits, validation documentation, and conservative qualification workflows, enabling proven Chinese bioprocess equipment and sterile consumables to achieve full compliance adaptation and steady supply.
EAEU & Central Asia Corridor
Navigating supranational EAEU registration and multi-center trials
Grounded in unified Eurasian Economic Union (EAEU) drug and device registration frameworks and clinical networks across Russian-speaking markets, we coordinate regulatory review, ethics alignment, and local commercial pathways to streamline cross-border trials and market entry.
Russia & EAEU
- —Multi-year track record in Russian life sciences and clinical translation
- —Academic research institute alignment and EAEU regulatory pathways
Central Asia
- —Market expansion and clinical partnerships in Kazakhstan
- —Healthcare and biopharma collaboration in Uzbekistan
Middle East
- —Strategic healthcare and life science initiatives in the UAE
- —Commercial and medical infrastructure collaboration in Saudi Arabia
Europe
- —Process engineering and biotech collaboration in Switzerland
- —Pediatric hemato-oncology cell therapy exchange in Italy
Japan & South Korea
- —Validated aseptic equipment and consumable delivery to Japanese pharma and CDMOs
- —Regional biomanufacturing supply chain collaboration in South Korea
Taiwan
- —CAR-T industrialization platform covering cell processing, lab planning, equipment integration, and supply chain support
Turkey
- —Partnerships with national and commercial blood centers and hospitals
- —Sterile medical devices, tube welders, and matched single-use consumables
Start a Cross-Border
Biopharma & Biotech Collaboration
Whether you are exploring cross-border pipeline licensing, custom automated bioprocess equipment, or supply chain integration in China, we welcome your inquiry. A managing partner for the relevant practice will respond within 3 business days.